by ASTCT Advocacy Update
ASTCT Submits Recommendations to OMB to Improve Access to Stem Cell and Cellular Therapies
by David Porter, MD
In this month's president's message, Dr. David Porter shares why staying engaged with ASTCT’s email communications is more important than ever.
by Alex Kadhim
Researchers from Siriraj Hospital, Mahidol University in Thailand demonstrated that haploidentical hematopoietic stem cell transplantation (haplo-HSCT), combined with post-transplant...
by Ami Bhatt, MD, PhD
This spotlight features Ami Bhatt, MD, PhD, the newly appointed Director of Laboratory Science on the ASTCT Board of Directors. A physician-scientist at Stanford University, Dr. Bhatt’s work...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Shernan Holtan welcomes Andrew Lin, Manager of Clinical Pharmacy Services of Adult BMT and CTS at Memorial Sloan Kettering Cancer Center, to discuss the...
by Alex Kadhim
Researchers from Massachusetts General Hospital and collaborating institutions conducted a prospective, multicenter phase II clinical trial demonstrating that prolonged administration of...